NCT07197502 Treatment of Borderline Personality Disorder With rTMS
| NCT ID | NCT07197502 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of California, Los Angeles |
| Condition | Borderline Personality Disorder |
| Study Type | INTERVENTIONAL |
| Enrollment | 30 participants |
| Start Date | 2025-03-01 |
| Primary Completion | 2027-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 30 participants in total. It began in 2025-03-01 with a primary completion date of 2027-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This project studies the effectiveness of brain stimulation on borderline personality disorder (BPD) symptoms. This study is blinded, randomized and will enroll up to 30 participants. Participant will be consented for the study remotely via a secure internet platform called Zoom. Participants will undergo up to 2 MRI scans, 2 brain wave recording sessions and up to 30 brain stimulation treatments, and complete symptom assessments and cognitive behavioral tasks on a computer. Participation requires minimum of 17 in person visits over the course of 2.5 months. Participants are randomly assigned active or sham brain stimulation. Participants who received sham brain stimulation have the option to receive additional 15 active brain stimulation session.
Eligibility Criteria
* Age of 18-65 * DSM-5 Diagnosis of BPD based upon a psychiatric evaluation and ZAN-BPD * Fluent English speaker * Signed informed consent
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07197502 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 65 Years, studying Borderline Personality Disorder. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07197502 currently recruiting?
Yes, NCT07197502 is actively recruiting participants. Contact the research team at EPinkerton@mednet.ucla.edu for enrollment information.
Where is the NCT07197502 trial being conducted?
This trial is being conducted at Los Angeles, United States, Los Angeles, United States.
Who is sponsoring the NCT07197502 clinical trial?
NCT07197502 is sponsored by University of California, Los Angeles. The trial plans to enroll 30 participants.